ZA972094B - Dosage forms and uses. - Google Patents

Dosage forms and uses.

Info

Publication number: ZA972094B
Authority: ZA; South Africa
Prior art keywords: dosage forms; verapamil; dosage form; single enantiomer; substantially single
Prior art date: 1996-03-11

Application number

ZA9702094A

Other languages

English (en)

Inventor

Julian Clive Gilbert

Original Assignee

Chiroscience Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-11

Filing date

1997-03-11

Publication date

1998-03-11

1997-03-11 Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd

1998-03-11 Publication of ZA972094B publication Critical patent/ZA972094B/xx

Links

239000002552 dosage form Substances 0.000 title abstract 3
SGTNSNPWRIOYBX-MHZLTWQESA-N (S)-verapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCC[C@](C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-MHZLTWQESA-N 0.000 abstract 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
SGTNSNPWRIOYBX-HHHXNRCGSA-N dexverapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCC[C@@](C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-HHHXNRCGSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA9702094A 1996-03-11 1997-03-11 Dosage forms and uses. ZA972094B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9605074.5A GB9605074D0 (en)	1996-03-11	1996-03-11	Dosage forms and uses

Publications (1)

Publication Number	Publication Date
ZA972094B true ZA972094B (en)	1998-03-11

Family

ID=10790173

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9702094A ZA972094B (en)	1996-03-11	1997-03-11	Dosage forms and uses.

Country Status (10)

Country	Link
US (1)	US6267980B1 (de)
EP (1)	EP0896530B1 (de)
JP (1)	JP2000506856A (de)
AT (1)	ATE219665T1 (de)
AU (1)	AU1932997A (de)
DE (1)	DE69713586T2 (de)
ES (1)	ES2179302T3 (de)
GB (1)	GB9605074D0 (de)
WO (1)	WO1997033570A1 (de)
ZA (1)	ZA972094B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997044025A1 (en) *	1996-05-23	1997-11-27	G.D. Searle & Co.	Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of r- and s-verapamil
US20030170181A1 (en) *	1999-04-06	2003-09-11	Midha Kamal K.	Method for preventing abuse of methylphenidate
US20030092765A1 (en)	2001-11-15	2003-05-15	John Kelly	Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
US20050159403A1 (en) *	2003-04-22	2005-07-21	Pharmacia Corporation	Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
US20050191245A1 (en) *	2004-02-27	2005-09-01	Adams Christopher P.	Nasal administration of calcium channel, blockers for treatment of hypertension and other cardiovascular disorders
US20080045603A1 (en) *	2006-08-04	2008-02-21	John Devane	Methods for treating at least one condition having MT1 receptor, 5HT2B receptor, and L-type calcium channel activity
EP3789022A1 (de) *	2012-12-27	2021-03-10	Massachusetts Eye & Ear Infirmary	Behandlung von rhinosinusitis mit p-glycoprotein-hemmern
MD3283067T2 (ro) *	2015-04-14	2020-05-31	Milestone Pharmaceuticals Inc	Săruri cu solubilitate mare în apă, cu acțiune scurtă a fenilalchilaminei ca blocant al canalului de calciu, și utilizarea acestora
WO2020198232A1 (en)	2019-03-25	2020-10-01	Massachusetts Eye And Ear Infirmary	Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5204116A (en)	1991-05-01	1993-04-20	Alza Corporation	Dosage form providing immediate therapy followed by prolonged therapy
DE4319438C1 (de) *	1993-06-11	1994-06-01	Gerd Dr Dr Geislinger	Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren

1996
- 1996-03-11 GB GBGB9605074.5A patent/GB9605074D0/en active Pending
1997
- 1997-03-11 WO PCT/GB1997/000674 patent/WO1997033570A1/en not_active Ceased
- 1997-03-11 DE DE69713586T patent/DE69713586T2/de not_active Expired - Fee Related
- 1997-03-11 JP JP9532367A patent/JP2000506856A/ja active Pending
- 1997-03-11 AU AU19329/97A patent/AU1932997A/en not_active Abandoned
- 1997-03-11 ES ES97907183T patent/ES2179302T3/es not_active Expired - Lifetime
- 1997-03-11 ZA ZA9702094A patent/ZA972094B/xx unknown
- 1997-03-11 US US09/142,705 patent/US6267980B1/en not_active Expired - Fee Related
- 1997-03-11 AT AT97907183T patent/ATE219665T1/de not_active IP Right Cessation
- 1997-03-11 EP EP97907183A patent/EP0896530B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US6267980B1 (en)	2001-07-31
AU1932997A (en)	1997-10-01
JP2000506856A (ja)	2000-06-06
EP0896530B1 (de)	2002-06-26
DE69713586T2 (de)	2003-01-09
DE69713586D1 (de)	2002-08-01
ES2179302T3 (es)	2003-01-16
GB9605074D0 (en)	1996-05-08
WO1997033570A1 (en)	1997-09-18
ATE219665T1 (de)	2002-07-15
EP0896530A1 (de)	1999-02-17

Publication	Publication Date	Title
ZA972685B (en)	1997-11-20	Medicaments.
ZA971324B (en)	1997-08-18	Powdered medication inhaler.
HU9603495D0 (en)	1997-02-28	1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
ZA989061B (en)	2001-07-05	Medicaments.
EP1080231A4 (de)	2004-01-14	Multimolekulare geräte, systeme zur wirkstoffverabreichung sowie selektion einzelner moleküle
ZA967502B (en)	1997-09-19	Medicament delivery device.
MX9602683A (es)	1997-06-28	Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
ZA967745B (en)	1998-03-13	Pharmaceutical formulations.
ZA969722B (en)	1998-05-20	Pharmaceutical formulations.
ZA965190B (en)	1997-12-19	Pharmaceutical composition.
ZA966777B (en)	1997-02-10	Inhaler.
ZA985364B (en)	1999-12-20	Pharmaceutical formulations containing voriconazole.
ZA977695B (en)	1998-02-23	1,4-heterocyclic metalloprotease inhibitors.
ZA9710927B (en)	1998-06-15	Pharmaceutical composition.
ZA9710071B (en)	1998-05-25	Pharmaceutical composition.
ZA964711B (en)	1997-12-08	Novel compounds, the preparation and use thereof.
ZA981029B (en)	1999-08-10	Pharmaceutical agents.
ZA200202521B (en)	2002-12-24	2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds.
ZA9811504B (en)	2000-06-15	Novel pharmaceutical.
ZA965712B (en)	1998-01-05	New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
ZA9811506B (en)	2000-11-06	Novel pharmaceutical.
ZA989680B (en)	1999-07-23	Pharmaceutical composition.
ZA9811505B (en)	2000-11-06	Novel pharmaceutical.
ZA968081B (en)	1998-03-26	Pharmaceutical composition.
GB9605074D0 (en)	1996-05-08	Dosage forms and uses